Edit
Strongbridge Biopharma
https://www.strongbridgebio.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 12.01.2022
Strongbridge is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs.
Total raised: $88M
Investors 5
| Date | Name | Website |
| - | CRG | crglp.com |
| - | Vivo Capit... | vivocapita... |
| 16.06.2021 | Longitude ... | longitudec... |
| - | Horizon Te... | horizontec... |
| - | TVM Capita... | tvm-lifesc... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.07.2017 | - | $53M | CRG |
| 30.12.2016 | - | $35M | - |
Mentions in press and media 24
| Date | Title | Description | Source |
| 12.01.2022 | Strongbridge Biopharma plc Reports Second Quarter 2021 Finan... | ~ Reports KEVEYIS® (dichlorphenamide) Second Quarter 2021 Revenue of $10.0 Million, a 28 Percent Inc... | healthcap.... |
| 17.07.2017 | Strongbridge Biopharma Secures $53 Million Financing From CR... | Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focus... | citybizlis... |
| 30.12.2016 | Strongbridge Biopharma Closes $35M Equity Financing and $40 ... | DUBLIN, Ireland and TREVOSE, Pa., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nas... | citybizlis... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 22.10.2015 | Insiders help Strongbridge limp to a downsized $25M IPO | Strongbridge Biopharma ($SBBP) has struggled through choppy conditions to complete a $25 million (€2... | fiercebiot... |
| - | Strongbridge Biopharma plc Announces Positive Top-Line Resul... | ~ SONICS Study Met Primary Endpoint with RECORLEV Demonstrating a Statistically Significant Normaliz... | healthcap.... |
| - | Strongbridge Biopharma plc to Present KEVEYIS® (dichlorphena... | ~ Post-Hoc Analysis of Phase 3 Placebo-Controlled Study of KEVEYIS Showed Adolescents had Similar Im... | healthcap.... |
| - | Strongbridge Biopharma plc Added to the NASDAQ Biotech Index | DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasd... | healthcap.... |
| - | A diagnostic odyssey: spotting the zebras among the horses | By Michele Cunningham While individually rare, collectively there are more than 7,000 rare diseases... | statnews.c... |
| - | Strongbridge Biopharma plc Reports Second Quarter 2018 Finan... | ~ Statistically Significant Positive Top-line Clinical Results Reported from SONICS Phase 3 Study of... | healthcap.... |
Show more